British sprinter Nigel Levine suspended for 4 years after failing the drugs test

To optimise for archiving, the original image and related documents associated with this article have been removed.

Nigel Levine, an elite athlete, who has competed at the Olympic Games, European and World Championships was provisionally suspended in February when found to have tested positive for the asthma drug clenbuterol.

Widely used to treat asthma, and other breathing disorders, clenbuterol has also been abused by athletes and bodybuilders to burn fat and boost aerobic capacity, hence its place on the World Anti-Doping Agency's prohibited list.

Levine was charged with an ADRV pursuant to Article 2.1 of the Anti-Doping Rules – “Presence of a Prohibited Substance or its Metabolites or Markers in an Athlete’s Sample"

UKAD stated that Levine’s ban will be backdated to December 13 2017 and run until December 12 2021.

Please click here to view UKAD's the full judgement.

You may also like

View All

WADA shares final drafts of the 2027 World Anti-Doping Code and International Standards and related documents

The World Anti-Doping Agency has shared its proposed final drafts of the 2027 World Anti-Doping Code and International Standards

Read More

Canadian Olympic and Paralympic Committees are calling for sport betting tax revenue to be reinvested into elite sport

The Canadian Olympic Committee and Canadian Paralympic Committee are calling for sport betting tax revenue to be reinvested into elite sport to help resolve the country’s funding crisis

Read More

Women in Sports Arbitration: Pathways and Perspectives

Join us during London Arbitration Week for an engaging panel with female arbitrators and professionals involved in arbitration processes, sharing their journeys, experiences, and insights into building careers in sports arbitration

Read More